South Korean (KOSPI) Healthcare Services Industry Analysis
UpdatedJan 29, 2023
DataAggregated Company Financials
Companies9
- 7D1.8%
- 3M-8.9%
- 1Y-2.8%
- YTD4.3%
In the last week, the Healthcare Services industry is up 1.1%, with Celltrion Healthcare up 2.1%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 8.1% per annum.
Industry Valuation and Performance
Has the South Korean Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 30 Jan 2023 | ₩11.9t | ₩3.1t | ₩180.7b | 23.9x | 66x | 3.8x |
| Wed, 28 Dec 2022 | ₩12.3t | ₩3.1t | ₩180.7b | 24.6x | 67.9x | 3.9x |
| Fri, 25 Nov 2022 | ₩12.6t | ₩3.1t | ₩223.1b | 25.4x | 56.7x | 4.1x |
| Sun, 23 Oct 2022 | ₩12.2t | ₩3.0t | ₩112.6b | 39.7x | 108.4x | 4.1x |
| Tue, 20 Sep 2022 | ₩13.0t | ₩3.0t | ₩112.6b | 40.4x | 115.6x | 4.3x |
| Thu, 18 Aug 2022 | ₩14.8t | ₩2.9t | ₩136.5b | 8.2x | 108.7x | 5.1x |
| Sat, 16 Jul 2022 | ₩13.6t | ₩2.9t | ₩136.5b | 8.5x | 99.7x | 4.7x |
| Mon, 13 Jun 2022 | ₩12.4t | ₩2.9t | ₩136.5b | 9.4x | 90.8x | 4.3x |
| Wed, 11 May 2022 | ₩11.7t | ₩2.8t | ₩133.0b | 10.5x | 88.2x | 4.2x |
| Fri, 08 Apr 2022 | ₩12.6t | ₩2.8t | ₩133.0b | 11.1x | 94.4x | 4.5x |
| Sun, 06 Mar 2022 | ₩12.9t | ₩2.6t | ₩228.6b | 8x | 56.6x | 5x |
| Tue, 01 Feb 2022 | ₩12.4t | ₩2.6t | ₩228.6b | 8.2x | 54.3x | 4.8x |
| Thu, 30 Dec 2021 | ₩15.8t | ₩2.6t | ₩228.6b | 8.8x | 68.9x | 6.1x |
| Sat, 27 Nov 2021 | ₩16.0t | ₩2.6t | ₩224.6b | 8.4x | 71.2x | 6.2x |
| Mon, 25 Oct 2021 | ₩17.0t | ₩2.6t | ₩210.5b | 14.1x | 80.9x | 6.5x |
| Wed, 22 Sep 2021 | ₩22.1t | ₩2.6t | ₩210.5b | 14.4x | 105.2x | 8.4x |
| Fri, 20 Aug 2021 | ₩20.1t | ₩2.6t | ₩211.0b | 12.9x | 95.2x | 7.6x |
| Fri, 04 Jun 2021 | ₩21.4t | ₩2.6t | ₩224.2b | 11x | 95.7x | 8.2x |
| Mon, 08 Mar 2021 | ₩22.0t | ₩2.6t | ₩228.9b | 10.4x | 96.1x | 8.4x |
| Thu, 10 Dec 2020 | ₩21.5t | ₩2.6t | ₩216.2b | 56.1x | 99.5x | 8.3x |
| Wed, 02 Sep 2020 | ₩17.8t | ₩2.4t | ₩128.3b | 86.5x | 138.7x | 7.6x |
| Sat, 06 Jun 2020 | ₩16.2t | ₩2.2t | ₩108.9b | 61.1x | 148.6x | 7.4x |
| Tue, 10 Mar 2020 | ₩12.0t | ₩2.0t | ₩113.8b | 14x | 105.8x | 6x |
Price to Earnings Ratio
97.5x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 65.7x which is lower than its 3-year average PE of 99x.
- The 3-year average PS ratio of 6.5x is higher than the industry's current PS ratio of 3.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 16% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | 3.72% | |
| Healthcare | 1.93% | |
| Healthcare Services | 1.83% | |
| Healthcare Facilities | 3.22% | |
| Healthcare Distributors | 1.74% | |
| Healthcare Services | 1.52% | |
| Managed Healthcare | 0% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 8.1% over the next 5 years.
- This is better than its past earnings decline of 20% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 8.1% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A091990 Celltrion Healthcare | ₩59.30k | 2.1% +₩193.6b | -1.3% | PE40.4x | |
| A085660 CHA Biotech | ₩14.09k | 3.2% +₩24.8b | -15.6% | PS1x | |
| A032940 Wonik | ₩4.46k | 6.3% +₩4.8b | 12.6% | PE3.6x | |
| A221800 U2Bio | ₩27.50k | 6.6% +₩3.2b | -13.7% | n/a | |
| A078160 MEDIPOST | ₩15.18k | 0.9% +₩2.1b | -14.0% | PE88.5x |